'A little company with a big vision': Temple spinout advancing new way to treat autoimmune disorders
The company, which is already testing a potential psoriasis treatment in humans, received FDA approval to conduct a Phase I trial for its experimental inflammatory liver disease treatment.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news
More News: Autoimmune Disease | Biotechnology | Health Management | Liver | Liver Disease | Psoriasis | Urology & Nephrology